Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Gentic Variations Contributing to Asthma Susceptability in Saudi Arabia

NCT01216215 is registered in ClinicalTrials.gov with King Saud University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01216215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Gentic Variations Contributing to Asthma Susceptability in Saudi Arabia
Lead sponsor
King Saud University
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
September 30, 2013
Enrollment
2,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

collection of clinical data that will be used in this study and will form a data bank for asthma in saudi arabia, identify known and novel genetic risk factors contributing to asthma susceptibility, study the mechanistic roles of the genetic variants within major asthma susceptibility genes